Browsing by Author Kostapanos, M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 12 to 15 of 15 < previous 
TitleAuthor(s)Issue date???itemlist.???
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Rosuvastatin administration decreases apolipoprotein CII and CIII serum levels in patients with primary dysilipidaemiaKostapanos, M.; Filippatos, T.; Gazi, I.; Saougos, V. G.; Milionis, H. J.; Kostara, C.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndromeFilippatos, T. D.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Balraktari, E. T.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)Milionis, H. J.; Rizos, E.; Kostapanos, M.; Filippatos, T. D.; Gazi, I. F.; Ganotakis, E. S.; Goudevenos, J.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-